Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relevance of CYP2D6 Gene Variants in Population Genetic Differentiation. | Pharmaceutics | 2022 | 36432672 | PubTator, text mining | PubMed |
| Assessment of Aging Impact on Wax Crystallization in Selected Asphalt Binders. | Materials (Basel) | 2022 | 36431732 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells. | Data Brief | 2022 | 36426076 | PubTator, text mining | PubMed |
| Complementary medicines used in ulcerative colitis and unintended interactions with cytochrome P450-dependent drug-metabolizing enzymes. | Turk J Med Sci | 2022 | 36422483 | PubTator, text mining | PubMed |
| Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant. | Front Pharmacol | 2022 | 36386142 | PubTator, text mining | PubMed |
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| Editorial: Insights in pharmacology of anti-cancer drugs: 2021. | Front Pharmacol | 2022 | 36339602 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin. | Breast Cancer Res | 2022 | 36284362 | PubTator, text mining | PubMed |
| The genetics of occupational asthma development among workers exposed to diisocyanates: A systematic literature review with meta-analysis. | Front Genet | 2022 | 36276967 | PubTator, text mining | PubMed |
| Genetic susceptibility of bladder cancer in the Lebanese population. | BMC Med Genomics | 2022 | 36253817 | PubTator, text mining | PubMed |
| Transfer RNA-derived small RNAs and their potential roles in the therapeutic heterogeneity of sacubitril/valsartan in heart failure patients after acute myocardial infarction. | Front Cardiovasc Med | 2022 | 36247465 | PubTator, text mining | PubMed |
| The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. | Front Genet | 2022 | 36246634 | PubTator, text mining | PubMed |
| Integrated multi-omics approach revealed cellular senescence landscape. | Nucleic Acids Res | 2022 | 36243980 | PubTator, text mining | PubMed |
| Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection. | Int J Mol Sci | 2022 | 36232610 | PubTator, text mining | PubMed |
| Mass spectrometry analysis of affinity-purified cytoplasmic translation initiation complexes from human and fly cells. | STAR Protoc | 2022 | 36181679 | PubTator, text mining | PubMed |
| The role of protein acetylation in carcinogenesis and targeted drug discovery. | Front Endocrinol (Lausanne) | 2022 | 36171897 | PubTator, text mining | PubMed |
| Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. | Toxicol Rep | 2022 | 36158865 | PubTator, text mining | PubMed |
| Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays. | Mol Cell Proteomics | 2022 | 36152753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=8